🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Colon Cancer Stage I

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer NCT06307548Phase 1, Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Aminolevulinic Acid, Biospecimen Collection, Computed Tomography, Fluorescence-Guided Surgery, Magnetic Resonance Imagi… Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors NCT05740956Phase 11 site📍 Beijing Jiangsu Hansoh Pharmaceutical Co., Ltd. · Tests: HS-10502 KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer NCT07353645Phase 1, Phase 21 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: KRAS Neoantigen Nanovaccine Partial Liver Segment 2/3 Transplantation Study NCT02215889Phase 1, Phase 21 site📍 Oslo Oslo University Hospital · Tests: Liver transplantation RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based NCT06614647NA9 sites📍 Herning📍 Randers📍 Aalborg University of Aarhus · Tests: Recurrence monitoring with circulating tumor DNA (ctDNA) as a high risk biomarker, Monitoring for late adverse effects … Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer NCT04511039Phase 11 site📍 Buffalo Roswell Park Cancer Institute · Tests: Trifluridine and Tipiracil Hydrochloride, Talazoparib Tosylate Efficacy of Hyperthermic Intraperitoneal Chemotherapy NCT04861558Phase 35 sites📍 Ahmedabad📍 Gothenburg📍 Malmö Uppsala University · Tests: 5Fluorouracil, Irinotecan, Oxaliplatin IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites📍 St Louis📍 Houston📍 San Antonio ViroMissile, Inc. · Tests: IDOV-Immune (oncolytic vaccinia virus) A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer NCT05093907Phase 1, Phase 21 site📍 Seoul BeyondBio Inc. · Tests: BEY1107, Capecitabine Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy NCT07419490NA1 site📍 Tampa University of South Florida · Tests: Uteroovarian transposition A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors NCT06004245Phase 155 sites📍 Tucson📍 Duarte📍 Irvine Vividion Therapeutics, Inc. · Tests: VVD-133214, Pembrolizumab, Bevacizumab Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study NCT04739072n/a10 sites📍 Gilbert📍 Jacksonville📍 Honolulu M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Electronic Health Record Review A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC NCT07255664Phase 1, Phase 21 site📍 Frankfurt CuraCell TX AB · Tests: CC-38, Pembrolizumab, Cyclophosphamid, Interleukin-2, Uromitexan A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors NCT06500052Phase 11 site📍 Guangzhou Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-M17D1 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites📍 Birmingham📍 Scottsdale📍 Little Rock Artios Pharma Ltd · Tests: ART0380, Gemcitabine, Irinotecan Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer NCT06696768Phase 113 sites📍 Gainesville📍 Shiloh📍 Fairway National Cancer Institute (NCI) · Tests: Bevacizumab, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Emavusertib Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer NCT07562659Phase 21 site📍 Shanghai Fudan University · Tests: Capecitabine Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma NCT07795528n/a1 site📍 Shanghai Ruijin Hospital · Tests: Longitudinal ctDNA-MRD NGS testing at scheduled postoperative time points A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors NCT07066657Phase 121 sites📍 Los Angeles📍 San Francisco📍 Aurora ArriVent BioPharma, Inc. · Tests: MRG007, MRG007 and Bevacizumab Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients NCT03190941Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Cyclophosphamide, Fludarabine, Anti-KRAS G12V mTCR PBL, Aldesleukin Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" NCT01365169NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Exercise Intervention, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring Family Communications After Genetic Testing NCT07143487NA360 sites📍 Anchorage📍 Anchorage📍 Anchorage Alliance for Clinical Trials in Oncology · Tests: Biospecimen Collection, Genetic Testing, Communication Intervention, Survey Administration Researching the Effect of Exercise on Cancer NCT04589468NA9 sites📍 Durate📍 San Carlos📍 Basking Ridge City of Hope Medical Center · Tests: Exercise A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites📍 Hangzhou📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: CEA-targeted CAR-T cells Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Best Practice, Biospecimen Collection, Endoscopic Procedure, Fecal Microbiota Transplantation, Infliximab HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer NCT07790510Phase 1, Phase 21 site📍 Beijing Haisco Pharmaceutical Group Co., Ltd. · Tests: HSK42360-Na Tablets, Cetuximab (EGFR inhibitor), mFOLFOX6 Regimen (Oxaliplatin/Leucovorin/5-FU), FOLFIRI Regimen (Irino… Virtual Rehabilitation for Cancer Survivors NCT05898789NA1 site📍 Toronto University Health Network, Toronto · Tests: CaRE@Home intervention Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases NCT03965234Phase 1, Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Cisplatin, Isolated Chemotherapeutic Lung Perfusion, Metastasectomy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy